Welcome to our dedicated page for EBR Systems SEC filings (Ticker: EBRCZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on EBR Systems's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into EBR Systems's regulatory disclosures and financial reporting.
EBR Systems, Inc. reported that Chief Financial Officer Gary W. Doherty received a grant of stock options covering 60,000 shares of common stock. The options have an exercise price of $2.6727 per share and expire on June 23, 2036.
These options were granted as compensation, with no cash paid at grant. According to the vesting schedule, 1/48 of the option shares will vest on July 24, 2026 and monthly thereafter, as long as he continues as a service provider. Following this grant, he holds 60,000 options directly.
EBR Systems, Inc. Schedule 13G/A — Regal Partners Funds Management Pty Limited and Regal Partners Limited report beneficial ownership of 87,510,124 ordinary shares, representing 11.62% of the class as disclosed in this amendment.
The filing lists shared voting power and shared dispositive power of 87,510,124 shares; signatures are dated 07/03/2026.
EBR Systems director Bronwyn Evans, together with Peter Douglas Gordon, exercised subscription rights to acquire 27,579 shares of Common Stock at A$3.80 per share. These shares represent common stock underlying 275,790 Chess Depositary Interests (CDIs) traded on the Australian Securities Exchange.
Following the transactions, their indirect holdings increased to 112,737 shares of Common Stock, representing common stock underlying 1,127,370 CDIs held via CHESS Depository Nominees. All activity reflects an exercise of in-the-money derivative rights rather than an open-market purchase or sale.
EBR Systems, Inc. director Bronwyn Evans reported two indirect acquisitions of common stock through exercises of in-the-money derivative securities. On June 15, 2026, entities "By Bronwyn Evans and Peter Douglas Gordon" exercised derivatives into 15,000 common shares at A$3.85 per share and another 15,000 shares at A$3.80 per share. The footnotes explain these represent the same number of Chess Depositary Interests traded on the Australian Securities Exchange and note that the reported beneficial ownership reflects a 1-for-10 reverse stock split effective April 1, 2026.
EBR Systems, Inc. is asking stockholders to approve two capital-actions at a virtual Special Meeting on August 19, 2026 (Australia) / August 18, 2026 (U.S.). The company previously issued 77,352,890 CDIs (equivalent to 7,735,289 shares) at A$0.38 on June 11–12, 2026 (Tranche 1). Proposal 1 seeks ratification under ASX Listing Rule 7.4 so those CDIs are excluded from the 15% placement capacity calculation. Proposal 2 seeks shareholder approval under ASX Listing Rule 10.11 to issue 92,105,270 CDIs (equivalent to 9,210,527 shares) at A$0.38 to specified investors (Tranche 2), which would raise approximately A$35.0 million if completed. The record date for voting is July 7, 2026; shares outstanding were 75,330,559 as of that date. The Board recommends voting FOR Proposals 1–3.
EBR Systems, Inc. director Bronwyn Evans reported two indirect acquisitions of common stock equivalents through exercises of in-the-money derivative positions. On June 15, 2026, entities associated with Evans and Peter Douglas Gordon acquired 15,000 common shares equivalent at A$3.85 per share and another 15,000 at A$3.80 per share. The footnotes explain these represent shares underlying the same number of Chess Depositary Interests, which trade on the Australian Securities Exchange and are held by CHESS Depositary Nominees.
EBR Systems, Inc. entered into an underwriting agreement for a fully underwritten A$150.0 million capital raise via the sale of approximately 394.7 million new CHESS Depository Interests (CDIs) on the ASX at A$0.38 per CDI, with ten CDIs representing one common share.
The structure includes an A$64.4 million institutional placement and an A$85.6 million 1-for-2 pro rata accelerated non-renounceable entitlement offer. The institutional placement and institutional entitlement offer are completed, while a conditional A$35.0 million tranche and a A$43.6 million retail entitlement offer remain subject to securityholder approval and future settlement. The offer price reflects discounts to recent trading prices and theoretical ex-rights price.
EBR Systems, Inc. reported its first meaningful commercial quarter, with Q1 2026 revenue of $2.4M from WiSE CRT System implants but a net loss of $17.1M and a gross margin of 7.8%. The company completed 41 commercial implants across 19 U.S. hospitals.
Cash, cash equivalents and marketable securities totaled $30.9M as of March 31, 2026, against noncurrent debt of $41.8M and negative operating cash flow of $20.3M for the quarter. Management discloses “substantial doubt” about EBR’s ability to continue as a going concern without raising additional capital.
Operating expenses rose sharply as EBR scaled commercialization, with research and development at $6.4M and selling, general and administrative expenses at $9.9M. Adjusted EBITDA was a loss of $15.1M, underscoring the need to grow procedure volumes or secure new funding to support ongoing operations and service upcoming debt maturities.
EBR Systems, Inc. director Will Allan R received a grant of stock options to buy 42,106 shares of common stock. The options have an exercise price of $3.7999 per share and expire on May 5, 2036. Following this award, he holds derivative rights over 42,106 underlying shares.
According to the vesting terms, 1/12 of the options will vest on June 6, 2026, with additional portions vesting monthly thereafter, as long as he continues as a service provider through each vesting date.
EBR Systems, Inc. director David Steinhaus received a grant of stock options covering 34,211 shares of common stock. The options have an exercise price of $3.7999 per share and expire on May 5, 2036. One-twelfth of the options will vest on June 6, 2026 and then monthly, as long as he continues as a service provider.